NS Partners’s Amgen AMGN Stock Holding History

NS Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.62M	Buy	+13,339	New	+$5.32M	0.24%	79
2018 Q4	–	Sell	-23,799	Closed	-$4.93M	–	92
2018 Q3	$4.93M	Sell	23,799 -6,074	-20%	-$1.2M	0.47%	71
2018 Q2	$5.51M	Hold	29,873	–	–	0.57%	70
2018 Q1	$5.09M	Sell	29,873 -446	-1%	-$81.9K	0.54%	71
2017 Q4	$5.27M	Buy	30,319 +383	+1%	+$67.8K	0.58%	65
2017 Q3	$5.58M	Buy	29,936 +9,528	+47%	+$1.69M	0.67%	62
2017 Q2	$3.52M	Buy	20,408 +1,267	+7%	+$206K	0.46%	73
2017 Q1	$3.14M	Sell	19,141 -8,493	-31%	-$1.41M	0.45%	75
2016 Q4	$4.04M	Sell	27,634 -706	-2%	-$106K	0.63%	68
2016 Q3	$4.73M	Sell	28,340 -41	-0.1%	-$6.93K	0.77%	56
2016 Q2	$4.32M	Sell	28,381 -6,074	-18%	-$944K	0.74%	57
2016 Q1	$5.17M	Buy	34,455 +2,473	+8%	+$367K	0.93%	44
2015 Q4	$5.19M	Sell	31,982 -3,327	-9%	-$523K	0.93%	43
2015 Q3	$4.88M	Sell	35,309 -741	-2%	-$117K	0.86%	54
2015 Q2	$5.53M	Buy	+36,050	New	+$5.77M	0.88%	53

Other funds holding AMGN

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

NS Partners's AMGN Position: Q3 2026 in Review

NS Partners opened a new position in Amgen (AMGN) in Q3 2026: 13,339 shares worth $5.62M. The stake represents 0.24% of the portfolio and ranks #79 among its holdings. This is a return to the name: NS Partners previously reported a position in AMGN as recently as Q3 2018.

NS Partners first reported a position in AMGN in Q2 2015 and has held it in 15 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

NS Partners held 13,339 shares of Amgen worth $5.62M as of Q3 2026.
Amgen was a new NS Partners position in Q3 2026.
Amgen made up 0.24% of NS Partners's portfolio in Q3 2026, its #79 holding.
NS Partners first reported a position in Amgen in Q2 2015 and has held it in 15 quarters since.
2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on NS Partners's 13F filing for Q3 2026, filed 10 Nov 2026.